4.85 USD
▼-0.20-3.96%
盘后 3.14 0.00%
2026-10-29
市值
$12.74M
市盈率
—
EPS
-22.01
股息率
—
52 周区间
1.31 – 9.53
成交量
2.27K
Beta
1.50
目标价
8.33
52W 低 1.3152W 高 9.53
价格走势
公司简介
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company’s lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.